(Q45411335)

14 December 2017

Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection (English)

1 reference

14 December 2017

1 reference

1 reference

1 reference

Edison R Parise

1

1 reference

14 December 2017

Ana C Oliveira

2

1 reference

14 December 2017

Cláudio Figueiredo-Mendes

3

1 reference

14 December 2017

Valéria Lanzoni

4

1 reference

14 December 2017

João Martins

5

1 reference

14 December 2017

Helena Nader

6

1 reference

14 December 2017

Maria L Ferraz

7

1 reference

14 December 2017

1 November 2006

1 reference

14 December 2017

1 reference

14 December 2017

26

1 reference

14 December 2017

9

1 reference

14 December 2017

1095-1099

1 reference

Noninvasive diagnosis of hepatic fibrosis or cirrhosis

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Treatment of cirrhotic patients in the pegylated interferon era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Fibrosis in patients with chronic hepatitis C: detection and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

The role of liver biopsy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Factors influencing the rate of fibrosis progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Biochemical markers of hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Serum hyaluronate correlates with histological progression in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2006.01356.X

10.1111/J.1478-3231.2006.01356.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference